Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
Ovarian cancer is a highly lethal disease among all gynecologic malignancies and is the fifth leading cause of cancer-related death in women. Although the standard combination of surgery and chemotherapy was initially effective in patients with ovarian cancer, disease relapse commonly occurred due t...
Main Authors: | Qinglei Zhan, Chunmei Wang, Saiming Ngai |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/916819 |
Similar Items
-
Ovarian cancer stem cells and targeted therapy
by: Vahideh Keyvani, et al.
Published: (2019-12-01) -
RuvBL2 is involved in histone deacetylase inhibitor PCI-24781-induced cell death in SK-N-DZ neuroblastoma cells.
by: Qinglei Zhan, et al.
Published: (2013-01-01) -
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
by: Sandra Muñoz-Galván, et al.
Published: (2020-06-01) -
Are ovarian cancer stem cells the target for innovative immunotherapy?
by: Wang L, et al.
Published: (2018-05-01) -
New perspectives on targeted therapy in ovarian cancer
by: Coward JIG, et al.
Published: (2015-02-01)